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Abstract
Outcome-dependent sampling designs are common in many different scientific fields
including ecology, economics, and medicine. As with all observational studies, such
designs often suffer from unmeasured confounding, which generally precludes the non-
parametric identification of causal effects. Nonparametric bounds can provide a way to
narrow the range of possible values for a nonidentifiable causal effect without making
additional assumptions. The nonparametric bounds literature has almost exclusively
focused on settings with random sampling and applications of the linear programming
approach. We derive novel bounds for the causal risk difference in six settings with
outcome-dependent sampling and unmeasured confounding. Our derivations of the
bounds illustrate two general approaches that can be applied in other settings where
the bounding problem cannot be directly stated as a system of linear constraints. We
illustrate our derived bounds in a real data example involving the effect of vitamin D
concentration on mortality.
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1 Introduction
The aim of empirical research is often to estimate the causal effect of a particular exposure
on a particular outcome. In observational (i.e. not randomized) studies, this is typically
complicated by the fact that there are confounders (i.e. common causes) of the exposure
and the outcome. Often, these confounders are at least partly unmeasured, in which case
the causal effect of interest is generally nonidentifiable as any observable association could
be due to the uncontrolled common causes.
One way to narrow the possible range of a nonidentifiable causal effect is to derive bounds,
i.e. a range of values that are guaranteed to contain the true causal effect given the true
distribution of the observed data. [e.g. Robins, 1989, Balke and Pearl, 1997, Zhang and
Rubin, 2003, Cai et al., 2008, Sjo¨lander, 2009]. Generally, the width of these bounds depends
on the amount of information provided by the study design; the more information the tighter
the bounds. In particular, Balke and Pearl [1997] showed that the bounds for the causal risk
difference may be substantially improved upon if an instrumental variable (IV) is available.
In their work, Balke and Pearl [1994] defined an algorithm for deriving valid and tight bounds
when the causal effect of interest and the constraints implied by the causal model (in the
sense of Pearl [2009]) can be stated as a linear optimization problem. Much of the subsequent
work on bounds has used this algorithm.
The literature on bounds for causal effects has focused on simple random sampling.
However, in many studies the probability of selection into the study depends on the outcome
of interest. Such outcome-dependent sampling often has advantages over simple random
sampling, such as increased statistical power when the outcome is rare, but it also complicates
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the analysis and interpretation of results [Didelez et al., 2010]. The case-control design, and
its variations, is perhaps the most common outcome-dependent design. Ideally, in this design,
the sampling only depends on the outcome, and not on other variables in the study; we refer
to this and all similar studies as uncounfounded outcome-dependent sampling. However, this
ideal is difficult to achieve in reality.
More often, selection will be confounded with the outcome and exposure. A test-negative
design is an example of a confounded outcome-dependent sampling design. In a test-negative
study, subjects are selected from the group of patients seeking health care for a particular
set of symptoms that are indicative of the disease of interest. Subjects are included in the
study if they are tested for disease status based on their symptoms, and the exposure of
interest is then retrospectively ascertained. This design, and variations of it, have been
discussed extensively in the literature [Sullivan et al., 2014, Sullivan and Cowling, 2015,
Sullivan et al., 2016]. An important difference between the case-control design and the test-
negative design is that, in the latter, potentially unobserved characteristics, such as the
subject’s lifestyle or health-seeking behavior, may influence whether the subject is tested
and therefore selected into the study. These characteristics may also be confounders for the
exposure (e.g. vaccination status) and the outcome of the study; we refer to this and all
similar studies as confounded outcome-dependent sampling.
In addition to being confounded with the outcome and exposure, sampling may directly
depend on the exposure. We refer to this as confounded exposure- and outcome-dependent
sampling. Although this is a setting that one hopes to avoid when sampling is outcome-
dependent, it may arise in test-negative studies when receiving the exposure reduces one’s
threshold for seeking medical treatment. This may also be the case in studies where the
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exposure is itself a medical condition and having such a condition leads to increased medical
monitoring and therefore an increased probability of being included in the study independent
of the outcome.
For each of these three sampling scenarios, we consider the bounds when there is and is
not an available IV. In the test-negative design, which is a confounded sampling, outcome-,
and possibly exposure-dependent setting, a possible IV is randomization of particular health
care centers to provide the exposure, for example a vaccine. Individuals at those health care
centers would then be free to decide if they wished to use the vaccine, regardless of their
randomized encouragement. For the unconfounded outcome-dependent sampling designs, a
possible IV may be a genetic allele, as in so-called Mendelian randomization studies [Bowden
and Vansteelandt, 2011].
In this paper we derive bounds for the causal risk difference under six versions of outcome-
dependent sampling, which cover if not all, most of the plausible outcome-dependent sam-
pling settings. As conditioning on sampling selection, as well as the lack of confounding of
the selection variable, do not result in a clearly linear problem, we cannot use the method
of Balke and Pearl [1994] without modification; see Balke [1995] for more detail. Therefore,
in addition to providing novel bounds in six relevant scenarios, we also provide an approach
to derive valid and informative bounds in some nonlinear scenarios and for modifying some
seemingly nonlinear settings so that they are linear programming problems, which to our
knowledge have not previously been described in the bounds literature. In addition, we
numerically compare the bounds derived in each setting to each other and random sampling
via simulations and in a real data example. This describes, in terms possibly easier to convey
to practitioners, the information loss associated with outcome-dependent sample selection.
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The paper is structured as follows. In Section 2 we define the causal target parameter,
provide basic definitions, assumptions and pertinent previously derived bounds. In Section
3 we present the bounds for the target parameter, and in Section 4 we carry out a simulation
study to assess the performance of the bounds. In Section 5 we provide a real data example,
before providing a summary of our results and a discussion of future work in Section 6.
2 Preliminaries
2.1 Notation
Let X and Y be the exposure and outcome of interest, and Y (x) be the potential (or
counterfactual) outcome for a given subject, if the exposure were set to level x [Rubin, 1974,
Pearl, 2009]. Let Z be a valid and available IV for X and Y ; we refer readers to Glymour
et al. [2012] for details on testing for validity of a candidate IV. We assume X, Y and Z are
all fully observed and binary. Let S be an indicator of being selected into the study; S = 1
for ‘selected’ and S = 0 for ‘not selected’. Let U represent the set of unobserved confounders
for X and Y , and sometimes S; there are no restrictions on the distribution of U . Thus,
the observed data distribution is given by p{Z,X, Y |S = 1}, when an IV is available, and
by p{X, Y |S = 1} when an IV is not available; p{·} denotes the probability mass function.
Because U is unmeasured, no counterfactual probabilities of the type p{Y (x) = y} are
identifiable in any of our settings of interest. Our target parameter is the most common
estimand used in nonparametric causal bounds, the causal risk difference
θ = p{Y (x = 1) = 1} − p{Y (x = 0) = 1}.
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For convenience of notation, we define several probability abbreviations. Let
pxy = p{X = x, Y = y},
pxy.s = p{X = x, Y = y|S = s},
pxys = p{X = x, Y = y, S = s},
pxy.zs = p{X = x, Y = y|Z = z, S = s},
pxys.z = p{X = x, Y = y, S = s|Z = z},
r = p{S = 1} and,
rz = p{S = 1|Z = z}.
2.2 Settings
The causal diagrams (as defined by Pearl [2009]) in Figures 1a, 1c, 1e and 1g illustrate ran-
dom, unconfounded outcome-dependent, confounded outcome-dependent, and confounded
exposure- and outcome-dependent sampling, respectively, without an available IV. The
causal diagrams in Figures 1b 1d, 1f and 1h illustrate the corresponding sampling schemes
with an available IV. The square around S in Figures 1c, 1d, 1e, 1f, 1g and 1h indicates that
the observed data distribution is conditioned on S = 1, i.e. on selection into the study. The
presence of an arrow from Y to S in the Figures makes the sampling outcome-dependent.
The absence of an arrow from U to S in Figures 1c and 1d makes the sampling unconfounded,
whereas the presence of this arrow in Figures 1e-1h makes the sampling confounded. In Fig-
ures 1b, 1d, 1f and 1h, Z has a causal effect on X. This is stronger than is necessary; in
order for Z to be a valid IV it is enough for Z to be associated with X.
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UX Y
(a) Random sampling, without IV.
Z
U
X Y
(b) Random sampling, with IV.
U
X Y S
(c) Unconfounded outcome-dependent sam-
pling, without IV.
Z
U
X Y S
(d) Unconfounded outcome-dependent sam-
pling, with IV.
U
X Y S
(e) Confounded outcome-dependent sam-
pling, without IV.
Z
U
X Y S
(f) Confounded outcome-dependent sam-
pling, with IV.
U
X Y S
(g) Confounded exposure- and outcome-
dependent sampling, without IV.
Z
U
X Y S
(h) Confounded exposure- and outcome-
dependent sampling, with IV.
Figure 1: Causal diagrams for eight possible study designs, two of which are random sampling
and the other six are outcome-dependent sampling.
2.3 Available information
To provide tight and valid bounds on θ when the sampling is confounded, we find it is
necessary to have knowledge of quantities that are not estimable from the observed data
distributions, p{Z,X, Y |S = 1} or p{X, Y |S = 1}, alone. In particular, we assume that
the sampling prevalence p{S = 1} is known. In finite populations, p{S = 1} is simply the
sample size divided with the population size. For example, in test-negative designs, p{S = 1}
could be considered the proportion of subjects who were tested for the disease status, among
the total number of eligible subjects that were initially included into the study. When one
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considers a super-population, p{S = 1} could be thought of as the true data generating
mechanism of sampling, which remains constant regardless of the infinite population, e.g.
flipping a coin for each new case or control that is encountered.
When there is an available IV (Figures 1d, 1f and 1h) we additionally assume that the
IV prevalence p{Z = 1} is known. When the IV is the randomization of health care centers
to provide the vaccine, as may be the case in a test-negative study, p{Z = 1}, is determined
by design. When the IV is a genetic allele, p{Z = 1} is often known from previous research.
We use the observed data distribution together with p{S = 1} and p{Z = 1} to calculate
p{S = 1|Z = z}, for z ∈ {0, 1}, as p{S = 1|Z = z} = p{Z = z|S = 1}p{S = 1}/p{Z = z}.
When the sampling is outcome-dependent but unconfounded, X is independent of S
given Y (Figures 1c and 1d). Therefore, if p{Y } were known, one could recover the uncon-
ditional distributions p{X, Y } and p{Z,X, Y } from the observed conditional data distribu-
tions. Thus, previously developed bounds for θ under random sampling could be applied.
However, knowing the outcome prevalence is not sufficient to recover the unconditional dis-
tributions p{X, Y } and p{Z,X, Y } when the outcome-dependent sampling is confounded
(Figures 1e-1h). Therefore, to allow for equitable comparison of the derived bounds, we
consider the same external information in all scenarios, i.e. p{S = 1}, without an IV and
p{S = 1} and p{Z = 1} with an IV.
2.4 Previous bounds
Robins [1989] derived bounds for θ under random sampling. Without an available IV, the
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bounds by Robins [1989] are given by
−(p01 + p10) ≤ θ ≤ 1− (p01 + p10). (1)
Robins [1989] also derived bounds in the setting when an IV is available. However, Balke
and Pearl [1997] showed that those bounds are valid but not tight, using the linear pro-
gramming method of bounds derivation developed in Balke [1995] and presented in Balke
and Pearl [1994]. Briefly, this method uses the fact that if all of the observed data prob-
abilities can be written as linear combinations of underlying counterfactual probabilities,
then maximizing and minimizing the causal risk difference, θ, under the linear constraints
defined by these relations is a linear programming problem. XXXXXX fix this Using
fundamental concepts in the field of linear programming, one can prove that the
global extrema obtained from the linear programming formulation yield bounds
that are tight [Dantzig, 1963]. “Tight” here means that all values inside the
bounds are logically compatible with the observed data distribution, under the
assumptions (e.g. causal diagram) that were used to derive the bounds. The
bounds derived by [Balke and Pearl, 1997] with an available IV are well known and have
been cited numerous times in the causal inference literature [e.g. Greenland, 2000, Frangakis
and Rubin, 2002, Herna´n and Robins, 2006]; we reproduce these bounds in Equations (1)
and (2) of the supplementary material.
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3 Novel Bounds
3.1 Unconfounded outcome-dependent sampling
Unconfounded outcome-dependent sampling is illustrated in Figures 1c and 1d, without and
with an available IV, respectively. The absence of an arrow from U to S in Figures 1c and
1d makes the derivation of bounds challenging. This is because the absence of this arrow
imposes nonlinear constraints, making the linear program method of Balke [1995] not directly
applicable. For these settings we define A(y, s) = p1y.s/p0y.s and B(y, z, s) = p1y.zs/p0y.zs.
Result 1:
The bounds given in (2) and (3) are valid for θ in the setting of Figure 1c provided that
p0y.1 6= 0 ∀y, or for θ∗ = −θ if x is replaced with x∗ = 1 − x everywhere in (2) and (3),
provided that p1y.1 6= 0 ∀y.
θ ≥ −(p01.1 + p10.1)r −max
{
1
1 + A(1, 1)
,
A(0, 1)
1 + A(0, 1)
}
(1− r) (2)
and
θ ≤ 1− (p01.1 + p10.1)r −min
{
1
1 + A(1, 1)
,
A(0, 1)
1 + A(0, 1)
}
(1− r). (3)
Result 2:
The bounds given in (4) and (5) are valid for θ in the setting of Figure 1e provided p0y1.z 6= 0
∀y, z, or for θ∗ = −θ if x is replaced everywhere in (4) and (5) with x∗ = 1 − x, provided
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that p1y1.z 6= 0 ∀y, z.
θ ≥ max

p11.11r1 + p00.01r0 − 1
p11.01r0 + p00.11r1 − 1
(p11.01 − p10.01 − p01.01)r0 − (p11.11 + p01.11)r1 − B(0,0,1)1+B(0,0,1)(1− r0)− (1− r1)
(p11.11 − p10.11 − p01.11)r1 − (p11.01 + p01.01)r0 − B(0,1,1)1+B(0,1,1)(1− r1)− (1− r0)
−(p10.11 + p01.11)r1 −max
{
1
1+B(1,1,1)
, B(0,1,1)
1+B(0,1,1)
}
(1− r1)
−(p10.01 + p01.01)r0 −max
{
1
1+B(1,0,1)
, B(0,0,1)
1+B(0,0,1)
}
(1− r0)
(p00.11 − p10.11 − p01.11)r1 − (p10.01 + p00.01)r0
−max
{
1
1+B(1,1,1)
,−1−B(0,1,1)
1+B(0,1,1)
}
(1− r1)− (1− r0)
(p00.01 − p10.01 − p01.01)r0 − (p10.11 + p00.11)r1
−max
{
1
1+B(1,0,1)
,−1−B(0,0,1)
1+B(0,0,1)
}
(1− r0)− (1− r1)

, (4)
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and
θ ≤ min

1− p10.11r1 − p01.01r0
1− p10.01r0 − p01.11r1
(p10.11 + p00.11)r1 + (p11.01 + p00.01 − p10.01)r0
+ (1− r1) + max
{
1−B(0,0,1)
1+B(0,0,1)
, B(1,0,1)
1+B(1,0,1)
}
r0
(p11.11 + p00.11 − p10.11)r1 + (p10.01 + p00.01)r0
+ max
{
1−B(0,1,1)
1+B(0,1,1)
, B(1,1,1)
B(1,1,1)
}
(1− r1) + (1− r0)
(p11.11 + p00.11)r1 + max
{
1
1+B(0,1,1)
, B(1,1,1)
1+B(1,1,1)
}
(1− r1)
(p11.01 + p00.01)r0 + max
{
1
1+B(0,0,1)
, B(1,0,1)
1+B(1,0,1)
}
(1− r0)
(p11.11 + p00.11 − p01.11)r1 + (p11.01 + p01.01)r0
+ max
{
1
B(0,1,1)
,−1−B(1,1,1)
1+B(1,1,1)
}
(1− r1) + (1− r0)
(p11.01 + p00.01 − p01.01)r0 + (p11.11 + p01.11)r1
+ max
{
1
B(0,0,1)
,−1−B(1,0,1)
1+B(1,0,1)
}
(1− r0) + (1− r1)

. (5)
Detailed derivations of Results 1 and 2 are in the supplementary material; we outline the
general concept here.
It can be shown (see the supplementary material) that the absent arrow from U to S in
Figure 1c implies the constraint,
A(y, 0) = A(y, 1) for all y, (6)
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and that the absent arrow from U to S in Figure 1d implies the constraint
B(y, z, 0) = B(y, z, 1) for all (y, z), (7)
provided that sampling was not deterministic, meaning that among the cases or controls
we samples randomly with probability between 0 and 1, i.e. 0 < p{S = 1|Y = y} < 1,
∀y. Although non-deterministic sampling is required for constraints (6) and (7) to hold,
the bounds derived from these constraints are valid provided that the ratios A(y, 1) and
B(y, z, 1) are not undefined, i.e. provided that the probabilities p0y.1 in the denominators of
A(y, 1) and p1y1.z in the denominators of B(y, z, 1) are not zero; detail provided below and
in the supplementary material.
To derive bounds for θ in the setting of Figure 1c that take the constraint in (6) into
account we proceed as follows. We partition the term p01 + p10 in (1) to
p01 + p10 = (p01.1 + p10.1)r + (p01.0 + p10.0)(1− r). (8)
We show in the supplementary material that, under the constraint in (6), the unobserved
part p01.0 + p10.0 is bounded by
p01.0 + p10.0 ≥ min
{
1
1 + A(1, 1)
,
A(0, 1)
1 + A(0, 1)
}
(9)
and
p01.0 + p10.0 ≤ max
{
1
1 + A(1, 1)
,
A(0, 1)
1 + A(0, 1)
}
. (10)
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We can then combine (9) and (10) with (1) to produce the bounds for θ. However, these
bounds are only valid and informative if A(y, 1) is defined; the ratio A(y, 1) is undefined
if p0y.1 = 0. A solution to this problem is to reverse the coding for the exposure, i.e. to
define a new exposure as x∗ = 1− x for which A(y, 1) are inverted. Replacing x everywhere
in (2) and (3) with x∗ we can obtain the lower bound, l∗, and upper bound, u∗, for θ∗ =
p{Y (x∗ = 1) = 1} − p{Y (x∗ = 0) = 1}. Since θ∗ = −θ, these translate into bounds for θ as
−u∗ ≤ θ ≤ −l∗.
This simple solution works for the bounds if the inverse ratios, A−1(y, 1), are not unde-
fined. However, this may not be the case. It is possible that p1y.1 = p0y.1 = 0 for some y,
so that both A(y, 1) and A−1(y, 1), are undefined. For such scenarios, we suggest using the
bounds in (11), for confounded sampling.
We now turn to Figure 1d. Arguing as we did for Figure 1c (see the supplementary
material for details) from the random sampling IV bounds of Balke and Pearl [1997] and
combining with (7) we arrive at valid bounds for θ in the setting of Figure 1d. These bounds
are given in (4) and (5). Just as above, when B(y, z, 1) is undefined for any y, z pair, we
can instead bound −θ by defining exposure as x∗ = 1− x, provided that B−1(y, z, 1) is not
undefined. When B−1(y, z, 1) and B(y, z, 1) are both undefined for a given y and all z, then
we suggest using the bounds given in (12) and (13), for confounded sampling in addition to
any remaining defined terms from (4) and (5).
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3.2 Confounded outcome-dependent sampling
Confounded outcome-dependent sampling is illustrated in Figures 1e and 1f, without and
with an available IV, respectively. Under Figure 1e the observed data distribution is given
by p{X, Y |S = 1}. If we know p{S = 1}, the joint probabilities p{X = x, Y = y, S =
1} = p{X = x, Y = y|S = 1}p{S = 1} are identifiable. Under Figure 1f the observed
data distribution is given by p{Z,X, Y |S = 1}. If we observe p{S = 1} and p{Z = 1} and
therefore, p{S = 1|Z}, the probabilities
p{X = x, Y = y, S = 1|Z = z} = p{Z = z,X = x, Y = y|S = 1}∑
x,y p{Z = z,X = x, Y = y|S = 1}
p{S = 1|Z = z}
are identifiable. This holds, respectively, for Figures 1g-1h, as well.
Result 3: The bounds for θ given in (11) are valid and tight in the setting of Figure 1e, and
the bounds given in (12) and (13) are valid and tight in the settings of Figure 1f, provided
that pxy1 ∀x, y (for Figure 1e) or that pxy1.z ∀x, y, z (for Figure 1f) are known.
p111 + p001 − 1 ≤ θ ≤ 1− p011 − p101. (11)
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For Figure 1f the resulting bounds are,
θ ≥ max

p001.1 − p011.0 − p111.0 + 2p111.1 − 1
p001.1 + p111.0 − 1
p001.0 + p111.1 − 1
p001.1 + p111.1 − 1
p001.0 − p011.1 + 2p111.0 − p111.1 − 1
−p001.0 + 2p001.1 − p101.0 + p111.1 − 1
p001.0 + p111.0 − 1
2p001.0 − p001.1 − p101.1 + p111.0 − 1
2p001.0 − p001.1 − p101.1 − p011.1 + 2p111.0 − p111.1 − 1
−p001.0 + 2p001.1 − p101.0 − p011.0 − p111.0 + 2p111.1 − 1

, (12)
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and
θ ≤ min

−p101.0 − 2p011.0 + p011.1 + p111.1 + 1
−p101.1 + p011.0 − 2p011.1 + p111.0 + 1
p001.1 − 2p101.0 + p101.1 − p011.0 + 1
−p101.0 − p011.1 + 1
−p101.1 − p011.0 + 1
−p101.0 − p011.0 + 1
p001.1 − 2p101.0 + p101.1 − 2p011.0 + p011.1 + p111.1 + 1
−p101.1 − p011.1 + 1
p001.0 + p101.0 − 2p101.1 − p011.1 + 1
p001.0 + p101.0 − 2p101.1 + p011.0 − 2p011.1 + p111.0 + 1

. (13)
To prove Result 3, we show (see the supplementary material), that given the probabilities
pxy1 (for Figure 1e) or pxy1.z (for Figure 1f), the problem of bounding θ can be expressed as
a linear programming problem. Solving the linear programming problems yields the bounds
in equations (11), and (12) and (13).
3.3 Confounded exposure- and outcome-dependent sampling
Confounded exposure- and outcome-dependent sampling is illustrated in Figures 1g and 1h,
without and with an available IV, respectively.
Result 4: The bounds for θ given in (11), and in (14) and (15) are valid and tight in the
settings of Figure 1g and Figure 1h, respectively, provided that pxy1 ∀x, y (for Figure 1g) or
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pxy1.z ∀x, y, z (for Figure 1h) are known.
θ ≥ max

p001.1 + p111.1 − 1
p001.0 + p111.1 − 1
p001.1 + p111.0 − 1
p001.0 + p111.0 − 1
2p001.1 + p011.0 + p111.0 + p111.1 − 2
2p001.0 + p011.1 + p111.0 + p111.1 − 2
p001.0 + p001.1 + p101.0 + 2p111.1 − 2
p001.0 + p001.1 + p101.1 + 2p111.0 − 2

, (14)
and
θ ≤ min

−p101.0 − p011.0 + 1
−p101.1 − p011.0 + 1
−p101.0 − p011.1 + 1
−p101.1 − p011.1 + 1
−p001.0 − p101.0 − p101.1 − 2p011.1 + 2
−p001.1 − p101.0 − p101.1 − 2p011.0 + 2
−2p101.0 − p011.0 − p011.1 − p111.1 + 2
−2p101.1 − p011.0 − p011.1 − p111.0 + 2

. (15)
Just as above, it can be shown that, given the probabilities pxy1 (for Figure 1g) or pxy1.z (for
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Figure 1h) are known, the problem of bounding θ can be expressed as a linear programming
problem. Solving the linear programming problem yields the bounds in (14) and (15). For
the setting of Figure 1g the resulting bounds are the same as for Figure 1h given in (11).
3.4 Comparison and refinement of the bounds
One would expect that the bounds in (2) and (3) (corresponding to Figure 1c) are at least
as wide as the bounds in (1), and that the bounds in (11) (corresponding to Figure 1e) are
at least as wide as the bounds in (2) and (3). Using the relations in (8), (9) and (10), it can
easily be shown that this is indeed the case.
However, a similar relation does not hold for the bounds corresponding to Figures 1d
and 1f. One can generate probabilities pzxy.1 which are possible in the setting of Figures 1d
(see supplementary material for specific scenario) where the bounds given by (12), (13) are
narrower than those given by (4), (5).
An important implication of the existence of such a scenario is that the bounds in (4) and
(5) are not tight. This is because, if they were, they would never be wider than any other
bounds for θ in the setting of Figure 1d based on the same information. In particular, they
would never be wider than the bounds in (12) and (13), since we assume the same available
information and the causal diagram in Figure 1d is a special case of the causal diagram in
Figure 1f, which implies that the bounds in (12) and (13) are also valid for Figure 1d.
This argument, however, suggests a simple way to improve the bounds in (4) and (5),
namely to replace them with the bounds in (12) and (13) whenever these are tighter. For-
mally, let ld and ud be the lower and upper bounds in (4) and (5), and let lf and uf be the
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lower and upper bounds in (12) and (13). We thus define new bounds for θ under the causal
diagram in Figure 1d as
max(ld, lf ) ≤ θ ≤ min(ud, uf ). (16)
We use these bounds for Figure 1f in the remainder of the paper.
4 Simulation
To compare the derived bounds we carried out a simulation study. We generated probability
distributions p{U,Z,X, Y, S} under the causal diagram in Figure 1h from the model
p{U = 1} ∼ Unif(0, 1)
p{Z = 1} ∼ Unif(0, 1)
p{X = 1|U,Z} = expit(α1 + α2U + α3Z + α4UZ)
p{Y = 1|U,X} = expit(β1 + β2U + β3X + β4UX)
p{S = 1|U, Y } = expit(γ1 + γ2Y + γ3U + γ4X)
(α1, α2, α3, α4, β1, β2, β3, β4, γ1, γ2) ∼ N(0, 5)
γ3 ∼ N(0, σ2U)
γ4 ∼ N(0, σ2X)

(17)
where expit(x) = ex/(1 + ex) and where e is Euler’s number. In this model, σU and σX
determine the degree of exposure dependence and confounding of the sampling; e.g. if
σU = 0, then the sampling is unconfounded, and if σX = 0, then the sampling does not
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depend on the exposure. We first generated 100,000 distributions p{U,Z,X, Y, S} from the
model in (17), with σU = σX = 0. For each distribution we computed our proposed bounds
corresponding to the assumed causal diagrams in Figures 1c-1h. For comparison we also
computed the previously derived bounds for random sampling, without [Robins, 1989] and
with an IV [Balke and Pearl, 1997]. We emphasize that these bounds use the distributions
p{X, Y } and p{Z,X, Y }, respectively, which do not condition on S = 1. Thus, these bounds
are not applicable when there is non-random (e.g. outcome-dependent) sampling.
Figure 2 shows the distribution of the width of the bounds. As expected, we observe
that an available IV generally makes the bounds narrower (b vs a, d vs c, f vs e, h vs g),
and that stronger deviation from the ideal randomized trial with random sampling generally
makes the bounds wider (a vs c vs e, b vs d vs f). However, an exception from the latter
is when exposure dependence is allowed for; the bounds under Figures 1g and 1e are always
identical, and the bounds under Figures 1h and 1f are often very similar, although not always
identical. The availability of an IV does not seem to generally ‘compensate’ for a non-ideal
sampling scheme; the median width under Figure 1d (outcome-dependent unconfounded
sampling, available IV) is larger than the median width under Figure 1a (random sampling,
no available IV), and the median width under Figure 1f (outcome-dependent confounded
sampling, available IV) is larger than the median width under Figure 1c (outcome-dependent
unconfounded sampling, no available IV).
We next repeated the simulation for σU = 0, 1, 2..., 10, holding σX fixed at 0 (top row of
Figure 3), and for σX = 0, 1, 2..., 10, holding σU fixed at 0 (bottom row of Figure 3). For
each combination of (σU , σX) we computed the median width of the bounds (left column of
Figure 3) and the proportion of time the bounds were violated (i.e. the proportion of times
21
a b c d e f g h
0.
0
0.
5
1.
0
1.
5
2.
0
scenario
w
id
th
Figure 2: Width of the bounds when σU = σX = 0 (unconfounded outcome-dependent
sampling).
22
the true causal risk difference is outside the bounds; right column of Figure 3). We observe
that the median width is virtually constant across σU and σX for all eight bounds. When
σU > 0, the bounds under Figures 1c and 1d are not generally valid, since these bounds
assume unconfounded sampling. Thus, when σU > 0 we would expect that these bounds
are sometimes violated. Similarly, when σX > 0, the bounds under Figures 1c, 1d and 1f
are not generally valid, since these bounds assume sampling that is not directly dependent
on the exposure. Thus, when σX > 0 we would expect that these bounds are sometimes
violated. We observe that, although violations do indeed occur when σU > 0, they are very
rare; at σU = 10 the bounds under Figures 1c and 1d are violated for less than 1% of all
simulated distributions. When σX > 0, violations appear to be relatively common for the
bounds under Figures 1d and 1f; at σX = 10 these bounds are violated for almost 10% of
all simulated distributions. However, the bounds under Figure 1c appear to be more robust,
with a the risk of violation less than 1% at σX = 10.
5 Real Data Example
To illustrate the performance of the bounds we use data from a real cohort study on Vitamin
D and mortality, described by Martinussen et al. [2019]. To allow for public availability, the
data were slightly mutilated before inclusion in the R package ivtools, whence we obtained
the data. The exposure (X) is vitamin D level at baseline, measured as serum 25-OH-D
(nmol/L). As vitamin D levels below 30 nmol/L indicate vitamin D deficiency [Martinussen
et al., 2019], we used this level as a cutoff for defining a binary exposure. The outcome
(Y ) is death during follow-up. The data also contain an IV, a binary indicator of whether
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Figure 3: Median width of the bounds (left column) and proportion violated (right column),
as a function of σU (top row) and σX (bottom row).
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the subject has mutations in the filaggrin gene. Martinussen et al. [2019] used this IV to
estimate the causal effect of vitamin D on mortality, assuming a parametric structural Cox
model. In contrast, the bounds that we have derived do not make any parametric model
assumptions.
The data constitute a random sample, which makes it possible to compute the bounds
corresponding to Figures 1a and 1b; these are given by (-0.74, 0.26) and (-0.71, 0.15),
respectively. Thus, for these data, the presence of an IV reduces somewhat the range of
possible values for θ.
To illustrate the impact of outcome-dependent sampling, we generated a selection vari-
able (S) randomly for each subject from a Bernoulli distribution with probability p{S =
1|Y = y} = expit(α + βy). Sampling is therefore dependent on the outcome, but is uncon-
founded and does not depend on the exposure. We set β to 0.5, to simulate sampling that is
moderately outcome-dependent. We used three values of α, corresponding to the marginal
selection probabilities p{S = 1} = (0.1, 0.5, 0.9).
For each level of sampling, we computed the bounds under the assumed DAGs in Figures
1c-1h; Table 1 shows the results. As in the simulation, we observe that an available IV
generally makes the bounds narrower, and that stronger deviation from the ideal randomized
trial with random sampling generally makes the bounds wider. As expected, we also observe
that all bounds become narrower as the probability of selection increases.
25
Assumed DAG p{S = 1} =
0.1 0.5 0.9
c (-0.90, 0.89) (-0.82, 0.61) (-0.75, 0.34)
d (-0.90, 0.76) (-0.81, 0.54) (-0.74, 0.21)
e (-0.96, 1.00) (-0.85, 1.00) (-0.76, 1.00)
f (-0.96, 0.84) (-0.81, 0.62) (-0.74, 0.21)
g (-0.96, 1.00) (-0.85, 1.00) (-0.76, 1.00)
h (-0.96, 0.88) (-0.84, 0.63) (-0.76, 0.26)
Table 1: Bounds for θ under outcome-dependent sampling of the vitamin D-data.
6 Discussion
We provide valid and informative nonparametric bounds for the causal risk difference under
six DAGs that cover a large number of settings for which, at least to our knowledge, the
bounds had not yet been derived. This provides a nearly complete set of bounds for outcome-
dependent sampling settings.
Although the Balke-Pearl method is the basis for our bounds, modifications and/or ex-
tensions to the method described in Balke [1995] were required in all settings, as none of
the settings clearly define linear programming problems. In addition, our procedure requires
modification of the algorithm to allow for the sampling variable S = 1 to define the ob-
served data distribution, which was not considered in Balke [1995], or, to our knowledge, in
subsequent literature.
As the unconfounded outcome-dependent sampling setting is not a linear optimization
problem under our assumed external information, the derivation for the bounds in this setting
is novel. Our approach also provides a possible route for the derivation of bounds in other
settings where the constraints are nonlinear due the lack of unmeasured confounding or lack
of complete observation, or both, for one or more variables.
In outcome-dependent sampling settings, the most common estimand is the odds ratio.
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This is because when sampling is uncounfounded (Figure 1c and 1d), the observed odds ratio
is collapsible over S and is therefore equal to the population (i.e. marginal over S) odds
ratio [Didelez et al., 2010]. However, in settings with unmeasured confounding of X and
Y , the observed odds ratio does not have a causal interpretation. In addition, when there
is confounding of the sampling, the observed odds ratio is no longer collapsible over S and
thus, not equal to the population odds ratio. Therefore, the odds ratio is not a better target
than any other causal estimand for our purposes, but is, in our opinion, less interpretable
than other estimands.
A setting we did not consider is uncounfounded exposure- and outcome-dependent sam-
pling. Although this is a possible scenario, we don’t see this as a likely scenario because a
practitioner would have to intentionally randomly sample conditional on both the outcome
and exposure. We also do not discuss scenarios where the exposure is randomized, but the
sampling is outcome-dependent and/or confounded with outcome. Although this is an inter-
esting set of problems, this is beyond the scope of this paper and an area of future research
for the authors.
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